← FDA ENFORCEMENT
D-0005-2025Class I

Gilead Sciences, Inc.

Recalling firm
Gilead Sciences, Inc.
Product type
Drug
Status
Terminated
Report date
2024-10-09
Distribution
Nationwide in the U.S.A.
Firm state
CA
Product quantity
105,000 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Presence of Particulate Matter: Presence of glass particle.

Product description

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Code / lot info

Lot: 47035CFA, Exp. 11/2025

Other recalls SPEQ maps to Environmental Monitoring
2026-07-22Class IArgon Medical Devices, Inc2026-07-22Class IIOlympus Corporation of the Americas2026-07-22Class IIChiesi USA, Inc.2026-07-22Class IICareFusion 213, LLC
See all Environmental Monitoring recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.